Angiotensin-converting enzyme I/D gene polymorphisms and effects of left ventricular hypertrophy in Turkish myocardial infarction patients

Acta Cardiologica

Volumn 59, Issue 5, 2004, Pages 493-497

  Karaali, Zeynep Ermis ^a,c   Agachan, Bedia ^b   Yilmaz, Hulya ^b   Isbir, Turgay ^b  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Hilal Apt No: 52/19 ^*  (Turkey)

Author keywords

Angiotensin converting enzyme polymorphism; Left ventricular hypertrophy; Myocardial infarction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; TURKEY (REPUBLIC);

ACUTE DISEASE; ALLELES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RISK FACTORS; TURKEY;

EID: 4944232158     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.59.5.2005221     Document Type: Article

References (44)

1. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Myocardial infarction and coronary deaths in the WHO-MONICA Project. Circulation 1994; 90: 583-612.
2. Wang XL, Tam C, McCredie RM, Wilcken DEL. Determinants of severity of coronary artery disease in Australian men and women. Circulation 1994; 89: 1974-8.
3. Slack J, Evans KA. Increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women with ischaemic heart disease. J Med Genet 1966; 3: 239-59.
4. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-6.
5. Jorde LB, Williams RR. Relation between family history of coronary heart disease and coronary risk variables. Am J Cardiol 1988; 62: 708-13.
6. Cambien F, Poirier O, Lecarf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tired L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin gene for angiotensin- converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
7. Libby P. Atherosclerosis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Huser SL, Long DL, eds. Harrison's Principles of Internal Medicine New York. McGraw-Hill, NY, 1998:1345-52.
8. Ehlers MR, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989; 28: 5311-8.
9. Erdos EG. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension 1990; 16: 363-70.
10. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-5.
11. Mattu RK, Needham EW, Gallon DJ, Frangos E, Clark AJ, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995; 91: 270-4.
12. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25: 950-3.
13. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk factor for CAD in Japanese. Circulation 1994; 90: 2199-202.
14. Gardemann A, Weils T, Schwartz O. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995; 92: 2796-9.
15. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993; 44: 292.
16. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-11.
17. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91: 2120-4.
18. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-3.
19. Winkelmann BR, Nauck M, Klein B, Russ AP, Bohm BO, Siekmeier R, Ihnken K, Verho M, Gross W, Marz W. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996; 125: 19-25.
20. Johanning GL, Johnston KE, Tamura T, Goldenberg RL. Ethnic differences in angiotensin converting enzyme gene polymorphism. J Hypertens 1995; 13: 710-1.
21. Morise T, Takeuchi Y, Takeda R. Angiotensin-converting enzyme gene polymorphism and essential hypertension (letter). Lancet 1994; 343: 125.
22. McKenzie CA, Julier C, Forrester T, McFarlane-Anderson N, Keavney B, Lathrop GM, Ratcliffe PJ, Farrall M. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitave-trait loci. Am J Hum Genet 1995; 57: 1426-35.
23. Keys A: Coronary Heart Disease in seven countries. 1970. Nutrition 1997; 13(3): 250-2.
24. WHO (Report of the joint International Society and Federation of Cardiology/World Health Organisation Task Force on standardization of clinical nomenclature) Nomenclature and criteria for diagnosis of ischaemic heart disease. Circulation 1979; 59: 607-9.
25. Miller SA, Dykes DD, Polesky HS. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
26. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase1). Nucleic Acids Res 1992; 20: 1433.
27. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bigham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetiere P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM study. Arterioscler Thromb 1992; 12: 701-7.
28. Bohn M, Berge KE, Bakken A, Eriksen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993; 44: 298-301.
29. Mattu RK, Needham EW, Galton DJ, Frangos E, Clark AJ, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study Circulation. 1995; 91: 270-74.
30. Talmud PJ, Watts GF, McBride S, Mandalia S, Brunt JN, Coltart DJ, Lewis B, Humphries SE. Angiotensin-converting enzyme polymorphism and the course of angiographically defined coronary artery disease. Atherosclerosis 1995; 114: 133-5.
31. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin-converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995; 112: 137-43.
32. Hamon M, Bauters C, Amant C, McFadden Ep, Helbecque N, Lablance JM, Bertrand ME, Amouyel P. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995; 92: 296-9.
33. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MJ. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
34. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmund PJ, McKenna WJ. Lack of asociation between angiotensin-converting enzyme gene and idiopathic dilated cardiomyophaty. J Am Coll Cardiol 1995; 25: 1627-31.
35. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertropic cardiomyopathy and sudden cardiac death. Lancet 1993; 342: 1085-6.
36. Schunkert H, Hense HW, Holmer SR, Slender M, Perz S, Keil U, Lorell B H, Riegger GA J. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. New Eng J Med 1994; 330: 1634-8.
37. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2626-8.
38. Ohishi M, Rakugi H, Higaki J, Miki T, Ogihara T. Angiotensin-converting enzyme genotype and ischemic heart disease. N Eng J Med 1995; 333: 459.
39. Samani NH, Thompson JR, O'Toole L, Channer K and Woods K L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-12.
40. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella GA. Angiotensin-converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994; 12: 955-7.
41. Chuang LM, Chiu KC, Chiang FT, Lee KC, Wu HP, Lin BJ, Tai TY. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metab Clin Exp 1997; 46: 1211-4.
42. Lee EJ. Population genetics of the angiotensin-converting enzyme in Chinese. Br J. Clin. Pharmacol 1994; 37: 212-4.
43. Nitiyanant W, Sriussadaporn S, Ploybutr S, Watanakejorn P, Tunlakit M and Bejrachandra S. Angiotensin-converting enzyme gene polymorphism in healthy Thais and patients with non-insulin-dependent diabetes mellitus. J Med Assoc Thailand 1997; 80: 747-52.
44. Pinto YM, Vangilst WH, Kingma JH, Schunkert H. Deletion type of the angiotensin-converting-enzyme gene is associated with progressive ventricular dysfunction after anterior myocardial infarction. J Am Coll Cardiol 1995; 25: 1622-6.